Track topics on Twitter Track topics that are important to you
SCOTTSDALE, Ariz., June 2, 2015 (GLOBE NEWSWIRE) -- Spirit Realty Capital, Inc. (NYSE:SRC) ("Spirit" or the "Company"), a premier net lease real estate investment trust (REIT) that invests in single-tenant, operationally essential real estate, today announced that Thomas H. Nolan, Jr., its Chairman and Chief Executive Officer, and Phil Joseph, its Chief Financial Officer, will be participating in NAREIT's REITWeek Investor Conference June 9 - 11, 2015 in New York, New York.
During the conference, Mr. Nolan will conduct a company presentation on Wednesday, June 10, 2015 at 9:30 a.m. ET. Listeners can access the audio webcast of the presentation through the Investor Relations section of Spirit's website at www.spiritrealty.com. Please access the webcast at least 15 minutes prior to the presentation to allow for registration and any necessary software downloading. The presentation will be archived for 90 days and will be available on the Company's website following the presentation.
About Spirit Realty Capital
Spirit Realty Capital, Inc. (NYSE:SRC) is a premier net lease real estate investment trust (REIT) that invests and manages single-tenant operationally essential real estate, which generally refers to free-standing, commercial real estate facilities where high-quality, middle-market tenants conduct retail, service or distribution activities that are essential to their sales and profits. As of March 31, 2015, our diverse asset portfolio was comprised of 2,547 assets, which are leased to 474 tenants operating in 27 different industries that span across 49 states, as well as the U.S. Virgin Islands. Initially formed in 2003, the Company completed its initial public offering in September 2012. More information about Spirit Realty Capital can be found at www.spiritrealty.com.
Forward-Looking and Cautionary Statements
This press release contains forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward‐looking statements can be identified by the use of words such as "expects," "plans," "estimates," "projects," "intends," "believes," "guidance," and other similar expressions that do not relate to historical matters. These forward‐looking statements are subject to known and unknown risks and uncertainties that can cause actual results to differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, Spirit's continued ability to source new investments, risks associated with using debt to fund Spirit's business activities (including refinancing and interest rate risks, changes in interest rates and/or credit spreads and changes in the real estate markets), unknown liabilities acquired in connection with acquired properties or interests in real‐estate related entities, general risks affecting the real estate industry (including, without limitation, the market value of our properties, the inability to enter into or renew leases at favorable rates, portfolio occupancy varying from our expectations, dependence on tenants' financial condition and operating performance, and competition from other developers, owners and operators of real estate), risks associated with our failure to maintain our status as a REIT under the Internal Revenue Code of 1986, as amended, and other additional risks discussed in Spirit's most recent filings with the Securities and Exchange Commission, including its Annual Report on Form 10‐K . Spirit expressly disclaims any responsibility to update or revise forward‐looking statements, whether as a result of new information, future events or otherwise, except as required by law.
CONTACT: FOR FURTHER INFORMATION CONTACT: Mary Jensen Vice President, Investor Relations (480) 315-6604 firstname.lastname@example.orgNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...